STOCK TITAN
  1. Home
  2. Sec-filings
  3. VNRX
  4. [EFFECT] VolitionRX Limited SEC Filing

[EFFECT] VolitionRX Limited SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 14, 2025 5:00 P.M.
Form: S-3
CIK: 0000093314
Company Name: VOLITIONRX LTD
File Number: 333-288508

Source: View Original Filing on SEC EDGAR

Stock VNRX logo
Volitionrx

NYSE:VNRX

VNRX Rankings

#5850 Ranked by Market Cap
N/A Ranked by Dividends
#39 Top Gainer

VNRX Latest News

Jan 30, 2026
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
Jan 27, 2026
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication
Jan 20, 2026
Volition Continues to Extend Access to Nu.Q® Vet Cancer Test
Jan 16, 2026
Volition Sponsors Symposium at Veterinary Meeting and Expo
Jan 8, 2026
VolitionRx Secures $2.0 Million in Funding

VNRX Latest SEC Filings

Jan 26, 2026
[PRE 14A] VOLITIONRX LTD Preliminary Proxy Statement
Jan 23, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity
Jan 23, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity
Jan 23, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity
Jan 23, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity

VNRX Stock Data

31.93M
101.74M
17.84%
22.29%
0.28%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
HENDERSON